Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate real-world effectiveness of elagolix in Canadian women with endometriosis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07240883 · Endometriosis
NCT05245695 · Endometriosis
NCT06212349 · Endometriosis, Chronic Pain, and more
NCT07578480 · Endometriosis
NCT07472842 · Endometriosis, Pelvic Pain Syndrome, and more
South Health Campus Rheumatology Clinic /ID# 213065
Calgary, Alberta
Aubrey D. Uretsky Professional Corporation /ID# 214753
Edmonton, Alberta
BC Women's Hospital /ID# 214561
Vancouver, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions